Global S-Amlodipine Market Growth 2023-2029

Global S-Amlodipine Market Growth 2023-2029

The global S-Amlodipine market size is projected to grow from US$ 34830 million in 2022 to US$ 75660 million in 2029; it is expected to grow at a CAGR of 11.7% from 2023 to 2029.

Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.

S AMLODIPINE belongs to a class of medicines called calcium channel blockers which are primarily taken to treat hypertension (high blood pressure) and angina (chest pain).

LPI (LP Information)' newest research report, the “S-Amlodipine Industry Forecast” looks at past sales and reviews total world S-Amlodipine sales in 2022, providing a comprehensive analysis by region and market sector of projected S-Amlodipine sales for 2023 through 2029. With S-Amlodipine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world S-Amlodipine industry.

This Insight Report provides a comprehensive analysis of the global S-Amlodipine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on S-Amlodipine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global S-Amlodipine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for S-Amlodipine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global S-Amlodipine.

This report presents a comprehensive overview, market shares, and growth opportunities of S-Amlodipine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Amlodipine Besylate Tablets
Amlodipine Mesylate Tablets
Amlodipine Maleate Tablets

Segmentation by application
Hypertension
Angina pectoris

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Aristo Pharmaceuticals Pvt Ltd
Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Angita Pharma
Florida DOH Central Pharmacy
Chengdu Di'ao Pharmaceutical Group Co., Ltd.
Yangzijiang Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global S-Amlodipine market?

What factors are driving S-Amlodipine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do S-Amlodipine market opportunities vary by end market size?

How does S-Amlodipine break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.